Using the "proportion of patients covered" and the Kaplan-Meier survival analysis to describe treatment persistence.

Lotte RasmussenNicole PrattMorten Rix HansenNina Sahlertz Kristiansen Jesper Hallas

Published in: Pharmacoepidemiology and drug safety (2018)

The KM survival analysis and the PPC method can be used to study different aspects of treatment persistence. Together, they provide a more complete picture of treatment persistence and drug use patterns.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
patient reported outcomes
free survival